The increasing weight of Crohn's disease subjects in clinical trials: a hypothesis-generatings time-trend analysis.
about
Interaction of obesity and inflammatory bowel diseaseThe Changing Phenotype of Inflammatory Bowel DiseaseObesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions.Perturbation of the human microbiome as a contributor to inflammatory bowel diseaseCombinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis.The microbiota in inflammatory bowel disease.Body fat composition assessment using analytic morphomics predicts infectious complications after bowel resection in Crohn's diseaseLocal chemerin levels are positively associated with DSS-induced colitis but constitutive loss of CMKLR1 does not protect against development of colitisQuality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn DiseaseExtraintestinal Manifestations Are Common in Obese Patients with Crohn's Disease.Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease.Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease.Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD.Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.Environment and risk of Crohn's disease: comments on "the increasing weight of Crohn's disease subjects in clinical trials".Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2004-2014.Editorial: visceral fat as a predictor of post-operative recurrence of Crohn's disease.Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab.Obesity and Crohn's disease: what comes first, the egg or the chicken?
P2860
Q28072225-958AB375-7DE1-4A07-8C6B-7A121ABB6ACDQ28354092-080F9219-5D95-4605-A2E6-9C8AB271DC5BQ30239737-01372D46-D901-49CD-87A3-B5D06D4A0FFDQ33829331-E5F65627-5E1D-46B6-93D7-E0245059819BQ34569117-5FDEFAFD-4517-4913-8136-8495A1D6640AQ35196243-060DBEC0-C0BB-439F-8339-3D0BD6515591Q35586660-81A45120-BD77-48E6-87D4-2A1B72D282C8Q35625006-CD931D87-18E3-435B-8668-9B2D26F9DFAFQ36036478-5C1CDC9F-C3DA-4024-8E07-BE30F4D62F03Q36838154-6A16B75F-32D0-4DD0-BDC7-368C7C3772ACQ38686671-6AF15BC1-F379-4491-8A8E-091EF8C048F6Q40662360-04540C65-3F59-4F5F-97C3-125B85180E66Q44209841-7E77F02A-3F0C-457E-B2F8-378724DCBBC7Q46003614-8C150C9D-7F1F-420E-827E-AB7596B897A9Q47118783-C93B2822-8D6D-46AD-AD36-A0E6D22512A7Q47182318-A48C694D-158A-45AE-BB5E-B67F967B7EDAQ47765146-CA76D140-4140-4125-B857-3FF6767843CBQ47886185-E7CF9BDC-E868-4206-9D78-56552CE2607AQ50496500-23AECB66-ADD7-456A-ADB2-EF70F423AF1DQ53154433-32885789-D858-41F6-AD92-4689350C9298
P2860
The increasing weight of Crohn's disease subjects in clinical trials: a hypothesis-generatings time-trend analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The increasing weight of Crohn ...... neratings time-trend analysis.
@en
type
label
The increasing weight of Crohn ...... neratings time-trend analysis.
@en
prefLabel
The increasing weight of Crohn ...... neratings time-trend analysis.
@en
P2860
P50
P1476
The increasing weight of Crohn ...... eneratings time-trend analysis
@en
P2093
Marie-France Dubeau
Remo Panaccione
P2860
P304
P356
10.1097/MIB.0B013E31829936A4
P577
2013-12-01T00:00:00Z